Molecular Dynamics Simulations of Influenza Hemagglutinin: Unveiling Conformational Changes for Vaccine Design

Introduction

Influenza A viruses cause significant economic losses and animal health burdens in poultry, swine, and equine populations worldwide. The viral hemagglutinin (HA) glycoprotein is the primary target for neutralizing antibodies and the main determinant of host range and receptor binding specificity. Hemagglutinin exists as a homotrimer on the virion surface, with each monomer composed of two subunits: the globular head domain (HA1) responsible for sialic acid receptor engagement and the stalk domain (HA2) that mediates membrane fusion [1, 2]. To design effective veterinary vaccines, especially universal platforms that confer broad protection against multiple subtypes, a mechanistic understanding of HA conformational dynamics is essential. Molecular dynamics (MD) simulations have emerged as a powerful computational tool to probe HA structural transitions at atomic resolution, complementing experimental methods such as X-ray crystallography and cryo-electron microscopy [3, 4]. This review synthesizes findings from MD studies on influenza HA, emphasizing receptor binding, pH-induced fusion, and implications for vaccine design in veterinary species.

Hemagglutinin Structure and Conformational Dynamics

The mature HA trimer adopts a metastable prefusion conformation on the viral envelope. Upon exposure to the acidic environment of the endosome (pH 5.0 to 6.0), HA undergoes irreversible conformational rearrangements that expose the fusion peptide and drive membrane fusion [1, 5]. The HA2 subunit contains a central coiled-coil region; its extension and refolding are critical for bringing the viral and host membranes into apposition [6, 7]. MD simulations have captured these large-scale motions, revealing that the loop-to-helix transition in HA2 is not a simple downhill event but involves multiple metastable intermediates [4]. Constant-pH MD studies have quantified the protonation states of key histidine and aspartate residues in the HA2 hinge region, providing a residue-level description of the pH trigger [8, 9]. The fusion peptide itself, a highly conserved N-terminal segment of HA2, inserts into the target membrane and disrupts lipid bilayer organization; MD simulations have shown that this peptide adopts a tilted orientation and causes local thinning, facilitating stalk pore formation [10, 11, 12].

Receptor Binding Dynamics and Host Tropism

Receptor binding specificity is a major barrier to cross-species transmission. Avian influenza viruses preferentially bind α-2,3-linked sialic acids, whereas mammalian adapted strains (swine, equine, human) favor α-2,6 linkages. Computational analysis of HA-receptor interactions through MD and free energy calculations has identified specific residues that govern this preference. For H5N1 HA, mutations such as N182K and Q226L alter the binding pocket shape and electrostatic complementarity, shifting affinity toward human-type receptors [13, 14]. Similar studies on H7N9 and H9N2 subtypes have shown that substitutions at HA positions 186, 198, and 226 modulate binding to avian versus mammalian glycans [15, 16]. The flexibility of the receptor binding site, particularly the 220-loop and the 190-helix, is captured only in explicit-solvent MD simulations; rigid crystal structures may obscure cryptic conformational states that enable adaptation [17, 18]. These simulation insights are directly relevant for risk assessment of zoonotic influenza viruses enzootic in poultry and swine populations.

MD Simulations in the Development of Fusion Inhibitors

The conserved nature of the HA2 fusion machinery makes it an attractive target for broad-spectrum antivirals and vaccine design. A number of small molecules and peptides have been shown to arrest HA in its prefusion state by binding to the stem region. MD simulations have elucidated the inhibitory mechanisms of arbidol and its derivatives against H3N2 HA, demonstrating that these compounds occupy a hydrophobic pocket between HA1 and HA2, stabilizing the trimer and preventing the low-pH conformational shift [19]. Similarly, the fusion inhibitor MBX2546 was shown via MD to interact with a conserved cavity in the HA2 stem, blocking the extrusion of the fusion peptide [20]. In the context of veterinary medicine, such inhibitors could be developed as therapeutic agents for outbreaks in swine and avian flocks, although vaccine-based strategies remain the primary control measure. MD studies on camphecene-resistant influenza mutants have explained reduced pathogenicity through altered HA stability, providing guidance for drug design [21].

Implications for Universal Veterinary Vaccine Design

The ultimate goal of influenza vaccine research is to elicit broadly protective antibodies that target conserved epitopes, particularly in the HA stem region. MD simulations have been instrumental in mapping the dynamic exposure of these epitopes. Mesoscale simulations of full-length HA trimers on a membrane patch revealed substantial breathing and tilting motions that transiently expose conserved stem epitopes normally hidden in the prefusion state [2]. These motions are now being exploited to design stabilized, prefusion-locked HA immunogens that present stem epitopes in a more immunogenic manner. For poultry applications, bioinformatics guided vaccine design using HA sequences from circulating avian influenza strains has identified conserved T-cell and B-cell epitopes; MD validation of these epitopes ensures they remain accessible on the dynamic protein surface [22].

Conformational changes in HA also affect antibody neutralization. Antigenic drift, driven by accumulation of point mutations in HA1, can alter epitope shape and charge. MD simulations combined with Markov state models have been used to predict escape mutations before they emerge in the field, aiding in annual vaccine strain selection for swine and equine influenza [23, 18]. For instance, the N156K mutation in the HA of A(H1N1)pdm09 was shown by MD to stabilize a loop conformation that reduces antibody binding affinity, facilitating cluster transition [23]. Deep mutational scanning and structural modeling have further refined these predictions, enabling proactive vaccine updates [1, 24].

Integration with Experimental Structural Biology

MD simulations are most powerful when integrated with experimental data. High-speed atomic force microscopy (HS-AFM) has captured real-time motions of HA trimers on the surface of influenza virions, revealing large-scale conformational fluctuations that match simulation ensemble predictions [3]. Combined NMR-computational approaches have characterized the interaction of HA with sialic acid derivatives on the surface of transfected cells, validating MD derived binding free energies [25]. Cryo-EM density maps of HA in intermediate states can be used as restraints in MD simulations, enabling the construction of complete free energy landscapes for the fusion process [4, 26]. This synergy is critical for designing immunogens that lock HA in a specific conformation for optimal antibody responses.

A Comparative Table of Key MD Studies on Influenza Hemagglutinin

Workflow of MD Simulations for HA Conformational Analysis

The typical pipeline for using MD simulations to study HA conformational changes is depicted below. It begins with structure acquisition from X-ray crystallography or cryo-EM, followed by system preparation, equilibration, production MD, and analysis.

flowchart TD
    A[Experimental HA Structure\n(X-ray, Cryo-EM)], > B[System Preparation\nSolvation, Ionization, Lipid Bilayer]
    B, > C[Energy Minimization &\nEquilibration (NVT, NPT)]
    C, > D[Production MD\n(Conventional or Enhanced Sampling)]
    D, > E[Trajectory Analysis\nRMSD, RMSF, Principal Component Analysis]
    E, > F[Key Observables\n-Protonation events\n-Receptor binding free energies\n-Stem epitope exposure]
    F, > G[Immunogen Design\nStabilized prefusion HA\nBroadly protective epitopes]

This workflow has been employed across multiple influenza subtypes and has guided the design of stabilized HA trimers for use in veterinary vaccines [22, 32, 2].

Key Considerations for Veterinary Vaccine Design

Several MD derived principles are particularly relevant for vaccine development in poultry, swine, and equine populations:

• Stabilization of the prefusion trimer. Mutations that introduce interprotomer disulfide bonds or fill hydrophobic cavities can increase HA thermostability and lock the protein in the prefusion conformation, which is more immunogenic for stem-directed antibodies [2, 26]. MD simulations can predict the effect of such stabilizing mutations before recombinant expression.

• Glycan shielding dynamics. The HA surface is extensively glycosylated; glycans can mask conserved epitopes from antibody recognition. MD simulations with explicit glycans show that glycan mobility varies across subtypes, influencing epitope accessibility [2, 6]. For vaccine antigens, it may be beneficial to remove specific glycosylation sites to expose vulnerable regions.

• Receptor binding pocket engineering. For inactivated whole-virus vaccines, altering the receptor binding pocket to reduce affinity for host receptors may improve safety while preserving immunogenicity [13, 14]. MD free energy calculations can guide rational design of such mutations.

• Cross-subtype conservation. The HA2 stem region is highly conserved across influenza A subtypes. MD simulations of stem epitopes in complex with broadly neutralizing antibodies have defined the precise side-chain conformations required for binding, enabling the design of epitope-focused immunogens [22, 2].

Cross-Linked Relevant Articles

Readers interested in related topics are encouraged to explore the following articles on this portal:

• Molecular Dynamics Simulations of Viral Envelope Protein Conformational Changes: Implications for Antiviral Targeting
• Predicting Receptor Binding Specificity of Zoonotic Influenza A Viruses Using Molecular Dynamics Simulations
• Computational Prediction and Design of Broadly Neutralizing Antibodies Against Influenza Hemagglutinin
• Structural and Evolutionary Dynamics of Influenza A Hemagglutinin Receptor-Binding Site: A Computational Approach to Predicting Host Tropism and Pandemic Potential
• Machine Learning-Driven Prediction of Antigenic Drift in Influenza A Hemagglutinin Using Structural Dynamics and Sequence Surveillance
• Structural Prediction and Evolutionary Dynamics of Avian Influenza Hemagglutinin Using Deep Learning and Molecular Dynamics
• Computational Design of Peptide Inhibitors Targeting the Hemagglutinin of Canine Influenza Virus
• Multiplex Real-Time RT-PCR for Simultaneous Detection of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), Porcine Circovirus Type 2 (PCV2), and Swine Influenza A Virus (SIV) in Oral Fluids: Assay Design and Field Validation
• High-Throughput Multiplex Real-Time RT-PCR for Simultaneous Detection and Subtyping of Avian Influenza Virus, Newcastle Disease Virus, and Infectious Bronchitis Virus in Poultry

Conclusion

Molecular dynamics simulations have become an indispensable tool for dissecting the conformational transitions of influenza hemagglutinin at atomic resolution. By capturing receptor binding dynamics, pH-sensitive fusion rearrangements, and epitope accessibility, MD studies directly inform the rational design of veterinary vaccines that are more broadly protective and less prone to antigenic drift. The continued development of enhanced sampling algorithms and integration with experimental data will further refine our ability to predict HA behavior and translate these insights into next-generation vaccines for poultry, swine, and equine species.

References

[1] Badiee SA, Govind Kumar V, Moradi M. Molecular Dynamics Investigation of the Influenza Hemagglutinin Conformational Changes in Acidic pH. J Phys Chem B 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39497238/

[2] Casalino L, Seitz C, Lederhofer J et al. Breathing and Tilting: Mesoscale Simulations Illuminate Influenza Glycoprotein Vulnerabilities. ACS Cent Sci 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36589893/

[3] Lim K, Kodera N, Wang H et al. High-Speed AFM Reveals Molecular Dynamics of Human Influenza A Hemagglutinin and Its Interaction with Exosomes. Nano Lett 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32787163/

[4] Lin X, Noel JK, Wang Q et al. Atomistic simulations indicate the functional loop-to-coiled-coil transition in influenza hemagglutinin is not downhill. Proc Natl Acad Sci U S A 2018. URL: https://pubmed.ncbi.nlm.nih.gov/30012616/

[5] Michalski M, Setny P. Molecular Mechanisms behind Conformational Transitions of the Influenza Virus Hemagglutinin Membrane Anchor. J Phys Chem B 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37877534/

[6] Lousa D, Soares CM. Molecular mechanisms of the influenza fusion peptide: insights from experimental and simulation studies. FEBS Open Bio 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34710289/

[7] Pabis A, Rawle RJ, Kasson PM. Influenza hemagglutinin drives viral entry via two sequential intramembrane mechanisms. Proc Natl Acad Sci U S A 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32188780/

[8] Lousa D, Pinto ART, Campos SRR et al. Effect of pH on the influenza fusion peptide properties unveiled by constant-pH molecular dynamics simulations combined with experiment. Sci Rep 2020. URL: https://pubmed.ncbi.nlm.nih.gov/33208852/

[9] Pathak AK. Effect of pH on the hinge region of influenza viral protein: a combined constant pH and well-tempered molecular dynamics study. J Phys Condens Matter 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29578453/

[10] Michalski M, Setny P. Membrane-Bound Configuration and Lipid Perturbing Effects of Hemagglutinin Subunit 2 N-Terminus Investigated by Computer Simulations. Front Mol Biosci 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35155580/

[11] Worch R, Dudek A, Borkowska P et al. Transient Excursions to Membrane Core as Determinants of Influenza Virus Fusion Peptide Activity. Int J Mol Sci 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34069905/

[12] Worch R, Dudek A, Krupa J et al. Charged N-terminus of Influenza Fusion Peptide Facilitates Membrane Fusion. Int J Mol Sci 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29443945/

[13] Ngo QB, Juffer AH. Theoretical Investigations of a point mutation affecting H5 Hemagglutinin's receptor binding preference. Comput Biol Chem 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39216409/

[14] Jeyaram RA, Radha CA, Gromiha MM et al. Design of fluorinated sialic acid analog inhibitor to H5 hemagglutinin of H5N1 influenza virus through molecular dynamics simulation study. J Biomol Struct Dyn 2020. URL: https://pubmed.ncbi.nlm.nih.gov/31594458/

[15] Zhu R, Wu J, Chen R et al. HA198 mutations in H9N2 avian influenza: molecular dynamics insights into receptor binding. Front Vet Sci 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39846021/

[16] Zhou X, Zheng J, Ivan FX et al. Computational analysis of the receptor binding specificity of novel influenza A/H7N9 viruses. BMC Genomics 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29764421/

[17] Xu H, Palpant T, Weinberger C et al. Characterizing Receptor Flexibility to Predict Mutations That Lead to Human Adaptation of Influenza Hemagglutinin. J Chem Theory Comput 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35815857/

[18] Yokoyama M, Fujisaki S, Shirakura M et al. Molecular Dynamics Simulation of the Influenza A(H3N2) Hemagglutinin Trimer Reveals the Structural Basis for Adaptive Evolution of the Recent Epidemic Clade 3C.2a. Front Microbiol 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28443077/

[19] Boonma T, Soikudrua N, Nutho B et al. Insights into binding molecular mechanism of hemagglutinin H3N2 of influenza virus complexed with arbidol and its derivative: A molecular dynamics simulation perspective. Comput Biol Chem 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36049355/

[20] Basu A, Komazin-Meredith G, McCarthy C et al. Molecular Mechanism Underlying the Action of Influenza A Virus Fusion Inhibitor MBX2546. ACS Infect Dis 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28301927/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[21] Borisevich SS, Gureev MA, Yarovaya OI et al. Can molecular dynamics explain decreased pathogenicity in mutant camphecene-resistant influenza virus? J Biomol Struct Dyn 2022. URL: https://pubmed.ncbi.nlm.nih.gov/33480324/

[22] Khursheed S, Ahmed MZ, Khursheed S et al. Bioinformatics-guided vaccine targeting the hemagglutinin protein of avian influenza virus. Mol Genet Genomics 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41686297/

[23] Tian Y, Jiang D, Ma W et al. Convergent evolution of the N156K mutation in A(H1N1)pdm09 hemagglutinin contributes to antigenic drift and cluster transition. Emerg Microbes Infect 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42267384/

[24] Pushan SS, Samantaray M, Rajagopalan M et al. Structural dynamics of influenza A (H1N1) hemagglutinin protein: a comparative study of Indian (2018) isolate with its evolutionary neighbor, Californian (2009) strain. J Biomol Struct Dyn 2025. URL: https://pubmed.ncbi.nlm.nih.gov/38379377/

[25] Vasile F, Panigada M, Siccardi A et al. A Combined NMR-Computational Study of the Interaction between Influenza Virus Hemagglutinin and Sialic Derivatives from Human and Avian Receptors on the Surface of Transfected Cells. Int J Mol Sci 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29695047/

[26] Boonstra S, Onck PR, van der Giessen E. Computation of Hemagglutinin Free Energy Difference by the Confinement Method. J Phys Chem B 2017. URL: https://pubmed.ncbi.nlm.nih.gov/29151344/

[27] Jeyaram RA, Priyadarzini TRK, Anu Radha C et al. Molecular dynamics simulation studies on influenza A virus H5N1 complexed with sialic acid and fluorinated sialic acid. J Biomol Struct Dyn 2019. URL: https://pubmed.ncbi.nlm.nih.gov/30686127/

[28] Perrier A, Eluard M, Petitjean M et al. In Silico Design of New Inhibitors Against Hemagglutinin of Influenza. J Phys Chem B 2019. URL: https://pubmed.ncbi.nlm.nih.gov/30590925/

[29] Leiva R, Barniol-Xicota M, Codony S et al. Aniline-Based Inhibitors of Influenza H1N1 Virus Acting on Hemagglutinin-Mediated Fusion. J Med Chem 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29220568/

[30] Kannan S, Kolandaivel P. Antiviral potential of natural compounds against influenza virus hemagglutinin. Comput Biol Chem 2017. URL: https://pubmed.ncbi.nlm.nih.gov/29149637/

[31] Guan S, Wang T, Kuai Z et al. Exploration of binding and inhibition mechanism of a small molecule inhibitor of influenza virus H1N1 hemagglutinin by molecular dynamics simulation. Sci Rep 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28630402/

[32] Nunthaboot N, Boonma T, Rajchakom C et al. Efficiency of membrane fusion inhibitors on different hemagglutinin subtypes: insight from a molecular dynamics simulation perspective. J Biomol Struct Dyn 2025. URL: https://pubmed.ncbi.nlm.nih.gov/38415365/

[33] Kannan S, Shankar R, Kolandaivel P. Insights into structural and inhibitory mechanisms of low pH-induced conformational change of influenza HA2 protein: a computational approach. J Mol Model 2019. URL: https://pubmed.ncbi.nlm.nih.gov/30904969/